“Givaudan announced the inauguration of its new high tech fermentation production line in Pomacle, France. The CHF 10 million investment in the extension of the production capacity represents Givaudan’s most important infrastructure investment in active cosmetic ingredients (ACI) to date.
This investment is another step in the Givaudan’s 2020 ambition to become a significant player in the ACI space. The new production line will support the Company in meeting the fast growing demand of our customers, particularly for products such as Hyaluronic Acid.
Frédérique Lafosse, Head of the Active Cosmetic Ingredients business, said: “This investment is a turning point in our efforts to serve customers in a timely manner, in particular for our blockbuster Soliance products.
The strong commitment of a transversal team bringing together people from Pomacle and other key Givaudan sites was essential to bring this project to life. We are very proud to inaugurate this modern production line today, and I take the opportunity to thank our teams and partners for the work done to make this new production line a reality”.”
Cet article n’engage que son auteur/ This article is the sole responsibility of the author